Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonist

被引：0
|
作者：
Mustafa Bahceci
Ulun Ulug
机构：
[1] Bahceci Women Health Care Center,
[2] Bahceci Women Health Care Center and German Hospital in Istanbul,undefined
来源：
Journal of Assisted Reproduction and Genetics | 2008年 / 25卷
关键词：
Progesterone; Vaginal; Intramuscular; IVF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：499 / 502
页数：3
相关论文
共 50 条
  • [1] Route of progesterone administration for luteal phase support may affect outcome of controlled ovarian hyperstimulation for IVF with ICSI using GnRH antagonist
    Bahceci, Mustafa
    Ulug, Ulun
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (9-10) : 499 - 502
  • [2] Prevention and treatment of OHSS by administration of GnRH antagonist in the early luteal phase of controlled ovarian hyperstimulation cycles
    Chen, Chunyan
    Liu, Lin
    Geng, Yuhong
    Yang, Chun
    Li, Tao
    Gao, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 2193 - 2198
  • [3] Luteal phase support with estradiol and progesterone versus progesterone alone in GnRH antagonist ICSI cycles: a randomized controlled study
    Madkour, Wael A. Ismail
    Noah, Bassel
    Hamid, Amr M. S. Abdel
    Zaheer, Hena
    Al-Bahr, Awatif
    Shaeer, Mahmoud
    Moawad, Ashraf
    HUMAN FERTILITY, 2016, 19 (02) : 142 - 149
  • [4] E2 support for luteal phase in GnRH antagonist IVF/ICSI cycle
    Roszaman, R.
    Omar, M. H.
    Nazri, Y.
    Azantee, Y. W.
    Murad, A. Z.
    Zainulrashid, M. R.
    HUMAN REPRODUCTION, 2010, 25 : I246 - I246
  • [5] Luteal phase progesterone and estradiol concentrations and their relation to the outcome of IVF/ICSI cycles with controlled ovarian stimulation
    Bakas, P.
    Simopoulou, M.
    Panagopoulos, P.
    Salakos, N.
    Siristatidis, Ch
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2019, 46 (05): : 727 - 730
  • [6] GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome
    Guiyarc'h-Leveque, A.
    Jaffre, F.
    Homer, L.
    Moy, L.
    Priou, G.
    Colleu, D.
    Denis, I.
    Arvis, P.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (09): : 511 - 514
  • [7] Does the Length of Ovarian Stimulation or Duration of GnRH Antagonist Use Affect Pregnancy Outcomes in IVF/ICSI Cycles Using a GnRH Antagonist?
    Royster, G. D., IV
    Robinson, R. D.
    Propst, A. M.
    Retzloff, M. G.
    FERTILITY AND STERILITY, 2009, 91 : S19 - S19
  • [8] Comparison of the luteal phase after pituitary suppression with GnRH-agonist versus GnRH antagonist in controlled ovarian hyperstimulation.
    Willman, SP
    Kliman, HJ
    FERTILITY AND STERILITY, 2005, 84 : S308 - S308
  • [9] Simultaneous initiation of GnRH antagonist co-treatment and recFSH for ovarian hyperstimulation in IVF does not affect clinical outcome: a randomized controlled trial
    Hamdine, O.
    Macklon, N. S.
    Eijkemans, M. J. C.
    Laven, J. S.
    Cohlen, B. J.
    Verhoeff, A.
    van Dop, P. A.
    Bernardus, R. E.
    Lambalk, C. B.
    Oosterhuis, G. J. E.
    Holleboom, C. A. G.
    van den Dool-Maasland, G. C.
    Verburg, H. J.
    van der Heijden, P. F. M.
    Blankhart, A.
    Fauser, B. C. J. M.
    Broekmans, F. J.
    HUMAN REPRODUCTION, 2013, 28 : 354 - 354
  • [10] Is exogenous LH necessary when using GnRH antagonist in IVF ovarian hyperstimulation?
    Noyes, N
    Chung, K
    Katz, J
    Krey, L
    FERTILITY AND STERILITY, 2002, 78 (03) : S22 - S22
12345